Answers are grounded in this paper and cite their sources.
Addition of BF(3).OEt(2) to ethereal solutions of the Ni(II) beta-diketiminates [Me(2)NN]Ni(R)(2,4-lutidine) (R = Et (1), Pr (2)) allows the isolation of the neutral beta-H agostic monoalkyls [Me(2)NN]Ni(R) (R = Et (3), Pr (4)). X-ray studies of primary alkyls 3 and 4a reveal acute Ni-C(alpha)-C(beta) angles with short Ni-C(beta) distances, indicating structures along the beta-H elimination pathway. Positional disorder of the alkyl group in the X-ray structure of 4 corresponds to partial (22%) occupancy by the secondary alkyl [Me(2)NN]Ni(CHMe(2)) (4b). Variable-temperature NMR spectra of 3 and 4 reveal fluxional behavior that result from beta-H elimination, in-plane rotation of the beta-CH(3) group, and a tetrahedral triplet structure for 3 that were investigated by density functional theory calculations at the Becke3LYP/6-31G level of theory without simplifications on the beta-diketiminate ancillary ligand. Calculations support low temperature NMR studies that identify the linear beta-H agostic propyl isomer 4a as the ground state with the branched beta-H agostic isomer 4b slightly higher in energy. NMR studies and calculations show that the beta-agostic 3 reluctantly coordinates ethene and that 3 is the ground state for this ethylene oligomerization catalyst. The thermodynamic isotope effect K(H)/K(D) = 1.3(2) measured for the loss of 2,4-lutidine from 1 to form beta-agostic 3 was also examined by DFT calculations.
No takes yet. Share an insight, caveat, or question.
Kogut et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: